| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/17/2014 | US20140107338 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 04/17/2014 | US20140107172 Benzimidazole-imidazole derivatives |
| 04/17/2014 | US20140107164 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 04/17/2014 | US20140107161 Insecticidal compounds based on arylthioacetamide derivatives |
| 04/17/2014 | US20140107160 Ccr9 inhibitors and methods of use thereof |
| 04/17/2014 | US20140107143 Quaternary opioid carboxamides |
| 04/17/2014 | US20140107139 Hydantoin derivatives as kv3 inhibitors |
| 04/17/2014 | US20140107128 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 04/17/2014 | US20140107125 Hydrazonopyrazole derivatives and their use as therapeutics |
| 04/17/2014 | US20140107122 Substituted Benzene Compounds |
| 04/17/2014 | US20140107120 Dual-acting benzoimidazole antihypertensive agents |
| 04/17/2014 | US20140107119 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 04/17/2014 | US20140107106 Therapeutic agents, and methods of making and using the same |
| 04/17/2014 | US20140107095 Estrogen receptor modulators and uses thereof |
| 04/17/2014 | US20140107073 GDF-8 Inhibitors |
| 04/17/2014 | US20140105920 Compositions and methods to treat disease characterized by cellular proliferation and angiogenesis |
| 04/17/2014 | US20140105898 Apoptosis-inducing molecules and uses therefor |
| 04/16/2014 | EP2719695A1 Azole derivative, method for producing azole derivative, and intermediate compound |
| 04/16/2014 | EP2719693A1 Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound |
| 04/16/2014 | EP2719688A1 Process for producing tetrazolyloxime derivatives |
| 04/16/2014 | EP2719687A1 Process to make a bromopicoline derivative |
| 04/16/2014 | EP2719686A1 Process to halogenate a picoline derivative |
| 04/16/2014 | EP2719685A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/16/2014 | EP2718285A1 Hydantoin derivates as kv3 inhibitors |
| 04/16/2014 | EP2718284A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS |
| 04/16/2014 | EP2718279A1 Novel compounds as modulators of gpr-119 |
| 04/16/2014 | EP2718267A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/16/2014 | EP2718266A1 Pyridin- 2 -amides useful as cb2 agonists |
| 04/16/2014 | CN103732590A Novel compounds for organic electronic material and organic electroluminescent device using same |
| 04/16/2014 | CN103728294A Applications of bisbenzimidazole bicarbazole compound in specific binding nucleic acid G-quadruplex structure and anti-tumor drug |
| 04/16/2014 | CN103724344A Method for synthesizing nitrogen-containing heterocyclic compound |
| 04/16/2014 | CN103724333A Synthetic method of Olmesartan Medoxomi I |
| 04/16/2014 | CN103724332A Method for preparing prucalopride impurity |
| 04/16/2014 | CN103724328A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 04/16/2014 | CN103724322A Androgen receptor modulators and uses thereof |
| 04/16/2014 | CN103724271A Substituted imidazole-1-ethylene compound and application thereof |
| 04/16/2014 | CN102675229B Preparation method for 2,5-dimethylpyrazine derivative |
| 04/16/2014 | CN102574836B Aminopyrazole derivative |
| 04/16/2014 | CN102333773B Mineralocorticoid receptor antagonist and methods of use |
| 04/16/2014 | CN102267986B Pyrazole bisamide compounds as well as synthesis method and application thereof |
| 04/16/2014 | CN102105934B Coloring matter for optical information recording medium and optical information recording medium |
| 04/16/2014 | CN101591332B Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof |
| 04/16/2014 | CN101585807B Azo compounds or their salts |
| 04/16/2014 | CN101578261B Heteroaryl-substituted serine amides |
| 04/15/2014 | US8697910 Optically active quaternary ammonium salt having axial asymmetry and process for producing α-amino acid and derivative thereof with the same |
| 04/15/2014 | US8697737 Raf modulators and methods of use |
| 04/15/2014 | US8697723 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases |
| 04/15/2014 | US8697721 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/15/2014 | US8697717 Inhibitors of histone deacetylase |
| 04/15/2014 | US8697698 Pyrazole compounds useful as protein kinase inhibitors |
| 04/15/2014 | US8697696 Triazole compounds II |
| 04/15/2014 | US8697690 Isoindolone M1 receptor positive allosteric modulators |
| 04/10/2014 | WO2014055603A1 Process for the preparation of an hiv integrase inhibitor |
| 04/10/2014 | WO2014055548A1 Anti-fibrotic pyridinones |
| 04/10/2014 | WO2014054912A1 Organic electroluminescent compounds and organic electroluminescent device comprising the same |
| 04/10/2014 | WO2014054635A1 Imidazole derivative |
| 04/10/2014 | WO2014054425A1 Amide compound |
| 04/10/2014 | WO2014053694A1 N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists |
| 04/10/2014 | WO2014053665A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/10/2014 | WO2014053491A1 Inhibitors of histone demethylases |
| 04/10/2014 | WO2014053210A1 Pyrrolidines |
| 04/10/2014 | WO2014023390A3 (aza-)isoquinolinone derivatives |
| 04/10/2014 | US20140100239 Quinazolinedione derivatives as parp inhibitors |
| 04/10/2014 | US20140100231 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2014 | US20140100230 Methods and compositions for treating anxiety |
| 04/10/2014 | US20140100215 Methods of Using PI3K and MEK Modulators |
| 04/10/2014 | US20140100214 Heterocyclic compounds and uses thereof |
| 04/10/2014 | US20140100213 Triazolones as fatty acid synthase inhibitors |
| 04/10/2014 | US20140100212 Compounds as tyrosine kinase modulators |
| 04/10/2014 | US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof |
| 04/10/2014 | US20140100210 Guanidine compound |
| 04/10/2014 | US20140099387 Compositions and methods for treatment |
| 04/10/2014 | US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
| 04/09/2014 | EP2716632A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/09/2014 | EP2714678A1 Imidazole derivatives |
| 04/09/2014 | EP2714662A1 Neprilysin inhibitors |
| 04/09/2014 | EP2714654A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group |
| 04/09/2014 | CN103717603A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 04/09/2014 | CN103717590A Quinazoline-7-ether compounds and methods of use |
| 04/09/2014 | CN103717588A Novel pyrazole derivative |
| 04/09/2014 | CN103717574A Novel compounds and compositions for the inhibition of nampt |
| 04/09/2014 | CN103710021A Fluorescent dye with nitrobenzimidazole as RNA (ribonucleic acid) recognition group as well as preparation method and application of fluorescent dye |
| 04/09/2014 | CN103709167A Novel method used for preparing ticagrelor capable of inhibiting platelet aggregation |
| 04/09/2014 | CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs |
| 04/09/2014 | CN103709097A 1,3-substituted carbamide or thiourea compound, preparation method thereof, pharmaceutical composition and application |
| 04/09/2014 | CN103709096A Urea type derivative used as nicotinamide ribose phosphate transferase inhibitor, as well as preparation method and application thereof |
| 04/09/2014 | CN103706395A Nano ruthenium catalyst and application thereof |
| 04/09/2014 | CN102603683B Furan compound and preparation method and application of furan compound |
| 04/09/2014 | CN102464622B Substituted pyrimidine ammine compound and application thereof |
| 04/09/2014 | CN102344446B Cis-nitenpyram analog containing carboxylic acid-substituted methyl ester and preparation method and application thereof |
| 04/09/2014 | CN102212031B Preparation method of 2-substituted-4-(piperidylmethyl) pyridine |
| 04/09/2014 | CN102026961B 酰胺化合物 Amide compounds |
| 04/08/2014 | US8692001 Sulfonamides for the modulation of PKM2 |
| 04/08/2014 | US8691857 EP4 agonist |
| 04/08/2014 | US8691848 Inhibitors of caspases |
| 04/08/2014 | US8691821 Oxazolidinones as modulators of mGluR5 |
| 04/08/2014 | US8691816 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents |
| 04/08/2014 | US8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 04/08/2014 | US8691184 Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same |
| 04/08/2014 | US8691002 Organic black pigments and their preparation |